Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by C4X Discovery Holdings PLC

PatientSeek identifies a genetic signature that separates a4b7 integrin therapy responder and non-responder populations in inflammatory bowel disease
From C4X Discovery Holdings PLC
Via GlobeNewswire
C4X Discovery Holdings plc: Half-year results for the six months ended 31 January 2023
From C4X Discovery Holdings plc
Via GlobeNewswire
C4XD and Garvan Institute of Medical Research report successful patient stratification approach using C4XD's new precision medicine platform PatientSeek
From C4X Discovery Holdings plc
Via GlobeNewswire
C4X Discovery Holdings plc: C4XD signs exclusive global licence worth up to $402 million¹ with AstraZeneca for the development and commercialisation of NRF2 Activator programme
From C4X Discovery Holdings plc
Via GlobeNewswire
Tickers AZN
C4X Discovery Receives Sanofi Milestone Payment
From C4X Discovery Holdings PLC
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.